December 3, 2014 | The California Institute for Regenerative Medicine and Israel’s Center for R&D, MATIMOP, will cooperate to advance stem cell research and regenerative medicine. The agreement, which will be signed on December 5th, lays out the foundation for a potential Californian-Israeli stem cell research programs, with the goal of making it easier for researchers to obtain funding. At the signing of the agreement in San Francisco, MATIMOP will be represented Michel Hivert. MATIMOP is the executive agency of the Office of the Chief Scientist and is the national agency for research and development in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Bolstering Young Startups With Angel Investor Fund
November 30, 2023

Israeli Medtech Companies Partner To Develop ‘Artificial Lung’
November 30, 2023

Cyber Startup Chosen To Secure Upcoming Tel Aviv Light Rail Line
November 29, 2023

Platform Battling Lies On Israel Expands Reach With 23 New Languages
November 29, 2023
Facebook comments